Male Infertility Treatment Market Size, Share, Growth, and Industry Growth by Type (DNA Fragmentation Technique, Oxidative Stress Analysis, Microscopic Examination, Sperm Agglutination, Computer Assisted Semen Analysis and Sperm Penetration Assay) By Application (Hospitals, Clinics and Others) Regional Forecast To 2031

Male Infertility Treatment Market Report Overview

• 
•  Request a Free Sample to learn more about this report

The male infertility treatment market size is expected to be USD 1.413 billion in 2022 and, the market is projected to touch USD 2.61 billion by 2030, exhibiting a Compound annual growth rate (CAGR) of 7.9% during the forecast period.

The market for male infertility treatments is expanding as a result of a variety of causes, including the dropping fertility rate, the expansion of fertility clinics throughout the world, the development of new technologies, and an increase in governmental and private subsidies and investments. However, it is anticipated that certain infertility treatment alternatives would be constrained in their ability to increase the market due to the high procedural costs of assisted reproductive technology treatments in developed economies and unfavorable regulatory laws.

DNA fragmentation technology is anticipated to continue expanding in the future due to its universal appeal and the ability of diagnostic tools to provide a reliable study of sperm DNA integrity. One of the primary causes of male infertility is DNA fragmentation in sperm. This method is used to identify male infertility for diagnostic purposes.

COVID-19 Impact: Permission for Urgent Medical Treatments Hindered the Market

Health services were significantly impacted by COVID-19. In the early stages of the pandemic, only urgent medical treatments were permitted. Depending on the market, the demand for medical treatments has decreased while it has increased for diagnostics, personal safety gear, and crucial medical supplies.

LATEST TRENDS

"Geographic Expansions and Acquisitions to Impel the Market demands"

Players are putting more emphasis on strategic agreements/partnerships with domestic and regional players, geographic expansions, and acquisitions in order to increase their presence in these markets and tap a large number of customers in order to take advantage of the significant growth opportunities in emerging countries. Government programs to make male infertility treatments more accessible as well as the rise in fertility clinics are also contributing to the increase in infertility treatment procedures in developing nations.

Male Infertility Treatment Market Segmentation

• 
•  Request a Free Sample to learn more about this report

• By Type Analysis

By type, market is segmented into DNA fragmentation technique, oxidative stress analysis, microscopic examination, sperm agglutination, computer assisted semen analysis and sperm penetration assay. The DNA fragmentation technique segment will dominate the market in the coming years.

• By Application Analysis

Based on applications, the market is classified into hospitals, clinics and others. The hospitals segment will lead the global share through 2030.

DRIVING FACTORS

"Age- Related Infertility Disorders to Push the Market"

Due to a number of factors, including the rising trend in late marriages and the rise in age-related infertility, the fertility rate is steadily declining throughout the world. The demand for infertility treatment products that determine both men and women's fertility windows has significantly increased as a result of this declining fertility rate.

"Development in Medical Tourism Business to Augment the Market "

Due to a variety of circumstances, the medical tourism business in developing nations is booming. Healthcare facilities in Asia are of a high standard, medical procedures are reasonably priced, and many of the medical professionals have received their training at prestigious institutions in the US and Europe. The market for male infertility treatments has a lot of room to develop in emerging nations like India, China, Singapore, Thailand, Brazil, and Malaysia.

RESTRAINING FACTORS

"Lack of Insurance Coverage and Regional Problematic Reimbursement Environment to Hamper the Market"

Thousands of rounds of ART procedures including in vitro fertilization (IVF) are carried out year throughout the globe in addition to reproductive surgery. Due to the absence of reimbursement rules, the cost of IVF therapy varies from nation to nation. The development of this market is being constrained by a lack of insurance coverage and a problematic reimbursement environment in several regions of the world.

Male Infertility Treatment Market REGIONAL INSIGHTS

• 
•  Request a Free Sample to learn more about this report

"Asia- Pacific to Hold Largest Global Male Infertility Treatment Market Share"

During the anticipated period, Asia Pacific is anticipated to see profitable growth. India, China, and Singapore are among the emerging nations in the area that have had rapid economic expansion. The growth of male infertility as well as improvements in medical diagnostics are driving the Asian market. The incidence rate of male infertility has increased as a result of the aging population's growth as well as the rise in disorders linked to lifestyle. Male infertility treatments are most popular in Asia Pacific. Increased awareness of male infertility treatment options, expansion of fertility centers in the region, rising healthcare costs, an increase in the infertility rate in the region, and government initiatives to make male infertility treatment more accessible in developing countries are all contributing factors to the region's significant increase in medical tourism.

During the anticipated period, Asia Pacific is anticipated to see profitable growth. India, China, and Singapore are among the emerging nations in the area that have had rapid economic expansion. The growth of male infertility as well as improvements in medical diagnostics are driving the Asian market. The incidence rate of male infertility has increased as a result of the aging population's growth as well as the rise in disorders linked to lifestyle.

KEY INDUSTRY PLAYERS

"Key Players Focus on Partnerships to Gain a Competitive Advantage "

Prominent market players are making collaborative efforts by partnering with other companies to stay ahead in the competition. Many companies are also investing in new product launches to expand their product portfolio. Mergers and acquisitions are also among the key strategies used by players to expand their product portfolio.

LIST OF TOP MALE INFERTILITY TREATMENT COMPANIES

• Merck Serono (Switzerland)
• Aytu BioScience (U.S.)
• Bayer (Germany)
• Cadila (India)
• Intas Pharma (India)
• Halotech DNA (Spain)
• SCSA diagnostics (U.S.)
• Andrology Solutions (U.K.)
• Livzon Pharmaceutical Group Inc. (China)
• Zhejiang Xianju Pharmaceutical Co.,Ltd. (China)
• GeneScience Pharmaceuticals Co., Ltd. (China)
• Abeona Therapeutics Inc. (U.S.)
• ASKA Pharmaceutical Co., Ltd. (Japan)
• Bristol Myers Squibb (U.S.)
• Church & Dwight (U.S.)
• Intas Biopharmaceuticals (India)
• Eli Lilly and Company (U.S.)

REPORT COVERAGE

The market research study examines the worldwide market in detail, focusing on important elements such as leading players, product/services or type, and leading end-use applications. Aside from that, the research analyses major advancements and provides insights into lighting market trends. In addition to the causes indicated above, the paper includes a number of other factors that have contributed to recent growth.